169 related articles for article (PubMed ID: 38035104)
1. Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C; Salamanca E; Palazón-Carrión N; Sánchez-Jiménez F; Pérez-Pérez A; Vilariño-García T; Fuentes S; Martín S; Jiménez M; Galván R; Rodríguez-Chacón C; Sánchez-Mora C; Moreno-Mellado E; Gutiérrez-Gutiérrez B; Álvarez N; Sosa A; Garnacho-Montero J; de la Cruz-Merino L; Rodríguez-Baño J; Sánchez-Margalet V
Front Immunol; 2023; 14():1266659. PubMed ID: 38035104
[TBL] [Abstract][Full Text] [Related]
2. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
Front Immunol; 2021; 12():801410. PubMed ID: 35154077
[TBL] [Abstract][Full Text] [Related]
3. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
Jiménez-Cortegana C; Liró J; Palazón-Carrión N; Salamanca E; Sojo-Dorado J; de la Cruz-Merino L; Pascual Á; Rodríguez-Baño J; Sánchez-Margalet V
Viral Immunol; 2021 Nov; 34(9):639-645. PubMed ID: 34529510
[TBL] [Abstract][Full Text] [Related]
4. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
5. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
Front Immunol; 2021; 12():748097. PubMed ID: 34659245
[TBL] [Abstract][Full Text] [Related]
6. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.
Emsen A; Sumer S; Tulek B; Cizmecioglu H; Vatansev H; Goktepe MH; Kanat F; Koksal Y; Arslan U; Artac H
Scand J Immunol; 2022 Jan; 95(1):e13108. PubMed ID: 34625989
[TBL] [Abstract][Full Text] [Related]
7. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Rowlands M; Segal F; Hartl D
Front Immunol; 2021; 12():697405. PubMed ID: 34220859
[TBL] [Abstract][Full Text] [Related]
9. Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
Koinis F; Vetsika EK; Aggouraki D; Skalidaki E; Koutoulaki A; Gkioulmpasani M; Georgoulias V; Kotsakis A
J Thorac Oncol; 2016 Aug; 11(8):1263-1272. PubMed ID: 27178984
[TBL] [Abstract][Full Text] [Related]
10. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
11. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients.
Kiaee F; Jamaati H; Shahi H; Roofchayee ND; Varahram M; Folkerts G; Garssen J; Adcock IM; Mortaz E
Sci Rep; 2022 Dec; 12(1):22570. PubMed ID: 36581679
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
Grassi G; Notari S; Gili S; Bordoni V; Casetti R; Cimini E; Tartaglia E; Mariotti D; Agrati C; Sacchi A
Front Immunol; 2022; 13():842949. PubMed ID: 35572540
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
Schrijver IT; Herderschee J; Théroude C; Kritikos A; Leijte G; Le Roy D; Brochut M; Chiche JD; Perreau M; Pantaleo G; Guery B; Kox M; Pickkers P; Calandra T; Roger T
Cells; 2024 Feb; 13(4):. PubMed ID: 38391927
[TBL] [Abstract][Full Text] [Related]
16. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Österberg B; Lautenbach MJ; Åhlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Sälde J; Albert J; Johansson N; Bell M; Loré K; Färnert A; Smed-Sörensen A
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33492309
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells in COVID-19: A review.
Perfilyeva YV; Ostapchuk YO; Tleulieva R; Kali A; Abdolla N; Krasnoshtanov VK; Perfilyeva AV; Belyaev NN
Clin Immunol; 2022 May; 238():109024. PubMed ID: 35489643
[TBL] [Abstract][Full Text] [Related]
18. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
Falck-Jones S; Österberg B; Smed-Sörensen A
J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19.
Bline K; Andrews A; Moore-Clingenpeel M; Mertz S; Ye F; Best V; Sayegh R; Tomatis-Souverbielle C; Quintero AM; Maynard Z; Glowinski R; Mejias A; Ramilo O
Front Pediatr; 2022; 10():893045. PubMed ID: 35733812
[TBL] [Abstract][Full Text] [Related]
20. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
